All In Biotech

Drug Trial Radar · NCT04356664

Benefit of GnRH Agonist Before Frozen Embryo Transfer in Patients With Endometriosis and/or Adenomyosis

Benefit of Gonadotropin-releasing Hormone (GnRH) Agonist Before Frozen Embryo Transfer in Patients With Endometriosis and / or Adenomyosis: Randomized Prospective Study

Last checked: Nov 20, 2026Latest source record: Jan 16, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

RecruitingPivotal-lookingPhase 3. Randomized with 180 participants. This is a heuristic, not a regulatory label.

Status

Recruiting

Enrollment

180

Planned (sponsor's estimate)

Start

Mar 18, 2021

Primary completion

Jun 18, 2026

Study completion Jun 18, 2026

Sponsor

Lead sponsor
Hopital FochAcademic, hospital or other
Sponsor type
Academic, hospital or other
First posted
Apr 22, 2020

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2 / Phase 3
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
FDA-regulated drug
No
Who can join
Female only, from 18 years, up to 36 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

Women suffering from endometriosis and/or adenomyosis may also suffer from infertility. GnRH agonist injection could improve implantation and therefore increase the pregnancy rate in these patients. This study was designed to evaluate effects of the additional of GnRH agonist (single or 2 doses) to the routine oestrogens and progestins use as support before Frozen Embryon Transfer as compared to oestrogens and progestins only.

Conditions

  • Endometriosis
  • Adenomyosis
  • Infertility, Female

Interventions

  • GnRH agonistDrug

    One or two intramuscular injections of Decapeptyl 3 mg

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Clinical pregnancy rate in both groups at last visit ultrasoundTime frame: 3 months after frozen embryon transfer

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Hopital Foch

    Suresnes, France · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.